GLSI
Greenwich LifeSciences
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
News
- Greenwich LifeSciences receives approval to expand the FLAMINGO-01 trial into the United KingdomJul 22, 2026
- Greenwich LifeSciences received European approval to use commercially manufactured GP2 in the FLAMINGO-01 trialJul 9, 2026
- Greenwich LifeSciences announced the use of commercially manufactured GP2 in the FLAMINGO-01 studyMar 16, 2026
- Greenwich LifeSciences reports 80% recurrence rate reduction in FLAMINGO-01 open label armDec 15, 2025
- Greenwich LifeSciences announces expansion of Flamingo-01 clinical trial to BelgiumOct 2, 2025